BE2016C017I2 - - Google Patents

Download PDF

Info

Publication number
BE2016C017I2
BE2016C017I2 BE2016C017C BE2016C017C BE2016C017I2 BE 2016C017 I2 BE2016C017 I2 BE 2016C017I2 BE 2016C017 C BE2016C017 C BE 2016C017C BE 2016C017 C BE2016C017 C BE 2016C017C BE 2016C017 I2 BE2016C017 I2 BE 2016C017I2
Authority
BE
Belgium
Prior art keywords
salmeterol
budesonide
solvate
component
salt
Prior art date
Application number
BE2016C017C
Other languages
French (fr)
Original Assignee
Galephar M/F
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galephar M/F filed Critical Galephar M/F
Publication of BE2016C017I2 publication Critical patent/BE2016C017I2/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Pharmaceutical composition for inhalation, containing as active ingredient effective amounts of salmeterol or a physiologically salt of salmeterol or a solvate thereof, and budesonide or a therapeutically salt of budesonide or a solvate thereof, wherein the molecular ratio of salmeterol component to budesonide component is in the range 1:2 to 1:50, together with a pharmaceutically acceptable carrier.
BE2016C017C 2001-08-07 2016-04-06 BE2016C017I2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
BE0100132 2001-08-07
PCT/BE2002/000132 WO2003013547A1 (en) 2001-08-07 2002-07-31 Pharmaceutical composition comprising salmeterol and budesonide for the treatment of respiratory disorders

Publications (1)

Publication Number Publication Date
BE2016C017I2 true BE2016C017I2 (en) 2021-07-19

Family

ID=50036776

Family Applications (1)

Application Number Title Priority Date Filing Date
BE2016C017C BE2016C017I2 (en) 2001-08-07 2016-04-06

Country Status (8)

Country Link
US (2) US20040247530A1 (en)
EP (1) EP1414468B1 (en)
AT (1) ATE284696T1 (en)
BE (1) BE2016C017I2 (en)
CA (1) CA2456721C (en)
DE (1) DE60202299T2 (en)
ES (1) ES2232769T3 (en)
WO (1) WO2003013547A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040191176A1 (en) * 2003-03-28 2004-09-30 Kaplan Leonard W Formulations for treatment of pulmonary disorders
SE527069C2 (en) 2003-06-19 2005-12-13 Mederio Ag Method and apparatus for administering drug powder
MX2013000642A (en) * 2010-07-16 2013-04-03 Cipla Ltd Pharmaceutical compositions comprising r (+) budesonide and one or more bronchodilators.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0009613D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Pharmaceutical compositions
AU2001278115A1 (en) * 2000-08-04 2002-02-18 Longwood Pharmaceutical Research, Inc. Formulations of mometasone and a bronchodilator for pulmonary administration

Also Published As

Publication number Publication date
CA2456721C (en) 2012-03-20
WO2003013547A1 (en) 2003-02-20
DE60202299T2 (en) 2005-12-08
ATE284696T1 (en) 2005-01-15
ES2232769T3 (en) 2005-06-01
US20080107740A1 (en) 2008-05-08
EP1414468A1 (en) 2004-05-06
US20040247530A1 (en) 2004-12-09
DE60202299D1 (en) 2005-01-20
CA2456721A1 (en) 2003-02-20
EP1414468B1 (en) 2004-12-15

Similar Documents

Publication Publication Date Title
AP1818A (en) Urea-compounds active as vanilloid receptor antagonists for the treatment of pain
GEP20074208B (en) Substituted amides active at the cannabinoid-1 receptor
PL365783A1 (en) 4-amino-6-phenyl-pyrrolo[2,3-d]pyrimidine derivatives
TR199500856A2 (en) Pharmaceutical composition that is taken by breathing in ice.
EP1283054A4 (en) Drugs for complications of diabetes and neuropathy and utilization thereof
CA2334411A1 (en) Use of a composition comprising formoterol and budesonide for the prevention or treatment of an acute condition of asthma
MXPA04004837A (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1.
IL161154A0 (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
CA2258095A1 (en) Tetrahydrolipstatin containing compositions
WO2002088100A3 (en) Deuterated 3-piperidinopropiophenone and medicaments containing said compounds
WO2004030611A3 (en) Non-nucleoside reverse transcriptase inhibitors
CA2386690A1 (en) Pharmaceutical tramadol salts
MX2007015480A (en) Solid dosage formulations of narcotic drugs having improved buccal adsorption.
HK1042303A1 (en) New compounds
WO2002030467A3 (en) Pharmaceutical composition containing honey for the treatment of wounds
WO1999061010A3 (en) Treatment of infertility with cam-increasing compounds alone or in combination with at least one meiosis-stimulating compound
CA2417935A1 (en) Anti-inflammatory medicament
AU2173101A (en) Use of carboxy compounds such as 2(4-acetoxyphenyl)-2-chloro-N-methyl-ethylammonium chloride as anti-inflammatory agents
HK1042493A1 (en) New compounds
MXPA02011533A (en) NOVEL FORMULATIONS OF agr; 2, 4 DISULFOPHENYL N TERT BUTYLNITRONE.
SE0000303D0 (en) Novel compounds
MXPA04005033A (en) Pharmaceutical composition comprising a combination of metformin and a 4-oxobutanoic acid, and the use thereof for treating diabetes.
MXPA02006034A (en) Oral mucosal dosage forms of apomorphine.
ATE284696T1 (en) PHARMACEUTICAL COMPOSITION CONTAINING SALMETEROL AND BUDESONIDE FOR THE TREATMENT OF RESPIRATORY DISEASES
WO2004033484A3 (en) Use of stable glutamine derivatives to improve drug absorption